· Weekly signal · AXSM
Axsome Therapeutics Inc (AXSM) extends its CNS-drug stock run
The weekly setup remains active, with improved market pressure offset by only moderate relative-strength confirmation.
Axsome Therapeutics Inc (AXSM) closed the latest week at 255.17 USD, up 9.8% for the week as the biotechnology stock continued to build on its recent advance.
The confirming evidence is constructive but not one-sided. Turnover was near normal at 3.44 million shares against a 3.48 million 13-week average, while Market Dynamics at 1.15 shows positive pressure and Relative Strength at 41.2 keeps confirmation measured in weekly context.